News Daily News The ‘Smoker’s Paradox’ Takes a New Hit From Long-term Analysis Yael L. Maxwell March 24, 2025
News Daily News Polymer-Free DES Hold No Long-term Advantage: ISAR-TEST-5 Michael O'Riordan July 07, 2020
News Daily News Stent-Related Adverse Events Continue Out to 5 Years: Meta-analysis Michael O'Riordan February 10, 2020
News Daily News TWENTE: Still Few Differences between ZES and EES at 2 Years L.A. McKeown May 03, 2013
News Conference News TCT 2012 Positive Long-Term Results from LEADERS, BioFreedom FIM, ISAR-TEST 5 October 24, 2012
News Conference News TWENTE: Zotarolimus DES Noninferior to Everolimus DES at 1 Year L.A. McKeown November 28, 2011
News Daily News ISAR-TEST 5 Published: Polymer-Free Dual DES Noninferior to Resolute Jason Kahn July 21, 2011